Keros Therapeutics, Inc. · NASDAQ:KROS
BlackRock, Inc. reported a 10.10% stake in Keros Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 7, 2026
BlackRock, Inc. reported a 10.10% stake in Keros Therapeutics, Inc., 1,990,842 shares, as a passive investor on Mar 31, 2026. Filed Apr 7, 2026 (Schedule 13G).
- Stake
- 10.10%
- Shares
- 1,990,842
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 10.10% | 1,990,842 |
Source
Related
- Keros Therapeutics, Inc.
- BlackRock, Inc.
- Keros Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Form 4 · Tanini Annita · Aug 20, 2026
- Form 4 · Lerner Lorena Raquel · Aug 20, 2026
- Form 4 · Cho Esther · Aug 20, 2026
- Form 4 · Newton Charles W. · Aug 20, 2026
- Form 4 · Bienaime Jean Jacques · Aug 19, 2026